A Georgia Tech student transformed her search to understand her mother's ALS into AI-driven research that could reshape how scientists study neurodegenerative diseases.

Parker H. Petit’s commitment will launch a research hub focused on using artificial intelligence to model diseases, identify treatment paths, and move discoveries closer to patient care.

While SpudCell is an important milestone in the field, it stops short of being a fully synthetic living cell.

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.

The science behind the buzz, as told by the guy who stood still.

The honorary society dates to the early days of the United States and honors excellence and contributions that advance society.

AI and machine learning provide new tools for scientists to think about drug discovery.

Researchers at Georgia Tech are using math, science, and artificial intelligence to better understand how people think, move, and perceive the world.

Milestone designation signals strong potential to reshape care for dialysis patients and those with chronic knee pain.

Georgia Tech researchers have developed a breakthrough system to manufacture valuable amino acids. It’s the most efficient system of its kind — and removes more carbon from the atmosphere than it emits.